BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Fuji
Federal Trade Commission
Julphar
Moodys
US Department of Justice
Accenture
Johnson and Johnson
Cantor Fitzgerald

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,696,481

« Back to Dashboard

Which drugs does patent 6,696,481 protect, and when does it expire?

Patent 6,696,481 protects PRESTALIA and is included in one NDA.

This patent has forty-one patent family members in thirty-six countries.
Summary for Patent: 6,696,481
Title: Salt of perindopril and pharmaceutical compositions containing it
Abstract:The present invention relates to a new salt of perindopril and to pharmaceutical compositions containing it, and Medicaments for treatment of hypertension and heart failure.
Inventor(s): Damien; Gerard (Orleans, FR), Lefoulon; Fran.cedilla.ois (Orleans, FR), Marchand; Bernard (Verneuil sur Seine, FR)
Assignee: Les Laboratoires Servier (Neuilly-sur-Seine, FR)
Application Number:10/371,865
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use;

Drugs Protected by US Patent 6,696,481

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Symplmed Pharms Llc PRESTALIA amlodipine besylate; perindopril arginine TABLET;ORAL 205003-001 Jan 21, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y Y TREATMENT OF HYPERTENSION ➤ Subscribe
Symplmed Pharms Llc PRESTALIA amlodipine besylate; perindopril arginine TABLET;ORAL 205003-002 Jan 21, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y Y TREATMENT OF HYPERTENSION ➤ Subscribe
Symplmed Pharms Llc PRESTALIA amlodipine besylate; perindopril arginine TABLET;ORAL 205003-003 Jan 21, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y TREATMENT OF HYPERTENSION ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,696,481

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 1787 ➤ Subscribe
Argentina 039428 ➤ Subscribe
Austria 271036 ➤ Subscribe
Australia 2003200700 ➤ Subscribe
Australia 2003222921 ➤ Subscribe
Brazil 0300709 ➤ Subscribe
Canada 2423825 ➤ Subscribe
China 1211365 ➤ Subscribe
China 1451656 ➤ Subscribe
Costa Rica 7576 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Chinese Patent Office
Boehringer Ingelheim
Fish and Richardson
Farmers Insurance
Baxter
Chubb
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot